Cg Oncology (CGON)Eventide Asset Management, LLC added to its stake +58K shares
Eventide Asset Management, LLC added to its stake in Cg Oncology, per its Q1 2026 13F.
- 370K
- Shares reported · +58K vs prior quarter
- 0.41%
- Disclosed portfolio weight
- $25M
- Reported value
- Holdings as of
- Mar 31, 2026
- Filed
- May 15, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 13, 2026, CG Oncology, Inc. (the “ Company ”) appointed Jim DeTore as the Company’s Chief Financial Officer. Mr. DeTore, age 61, has served as our Interim Principal Financial and Accounting Officer since November 2025 pursuant to a consulting agreement with Monomoy Advisors, LLC, and has been responsible for the Company’s financial and accounting functions.”
- May 8, 2026Company filing · Form 8-K · ResultsReported its results
What came next
- May 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 20, 2026, CG Oncology, Inc. (the “ Company ”) and Ambaw Bellete, the Company’s President & Chief Operating Officer of the Company, agreed to his separation from the Company to be effective June 30, 2026.”
- Aug 6, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Cg Oncology
For Cg Oncology, OQRO holds 4 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CGON page.
How this filing works
Other disclosures at Cg Oncology
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRMay 15, 2026
Everything OQRO holds on this company is on its CGON page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
